Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC-01 Nasal Spray for Dry Eye Disease
NCT03636061Phase 2Completed
- Sponsor
- Oyster Point Pharma
- Start
- Aug 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline + nicotine patch in dry eye disease (DED), sponsored by Oyster Point Pharma. Started Aug 2018; status: completed.
02
Drugs
varenicline + nicotine patch
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03636061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03636061.